Bain Capital Public Equity Management II’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bain Capital Public Equity Management II’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-575,301	Closed	-$7.66M	–	44
2019 Q4	$7.66M	Sell	575,301 -22,853	-4%	-$252K	0.73%	27
2019 Q3	$5.13M	Sell	598,154 -208,550	-26%	-$2.03M	0.49%	34
2019 Q2	$8.82M	Buy	+806,704	New	+$9.04M	0.81%	29

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bain Capital Public Equity Management II's IRWD Position: Q1 2020 in Review

Bain Capital Public Equity Management II sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2020, closing a stake of 575,301 shares — an estimated $7.66M sold.

Bain Capital Public Equity Management II first reported a position in IRWD in Q2 2019 and held it in 3 quarters. The position peaked at $8.82M in Q2 2019. 193 funds tracked by Wall St. Rank hold IRWD as of Q1 2020.

Bain Capital Public Equity Management II reported no remaining Ironwood Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Bain Capital Public Equity Management II sold 575,301 Ironwood Pharmaceuticals shares in Q1 2020, an estimated $7.66M.
Bain Capital Public Equity Management II first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 3 quarters.
Bain Capital Public Equity Management II's Ironwood Pharmaceuticals position peaked at $8.82M in Q2 2019.
193 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2020.

Based on Bain Capital Public Equity Management II's 13F filing for Q1 2020, filed 15 May 2020.